Market Tracker

12/08 5:16pm ET

Alere Inc (NYSE:ALR)

37.35
Delayed Data
As of Dec 08
 +0.68 / +1.85%
Today’s Change
31.47
Today|||52-Week Range
54.13
-4.45%
Year-to-Date
Trump Claims Next Corporate Victims, AT&T-TWX Kick Off Hearing: In Case You Missed it...
Dec 07 / TheStreet.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
Abbott Looks to Kill Alere Deal
Dec 07 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close36.67
Today’s open36.86
Day’s range36.77 - 37.48
Volume1,346,961
Average volume (3 months)797,978
Market cap$3.2B
Dividend yield--
Data as of 4:02pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-212.07%
Earnings growth (this year)-47.50%
Earnings growth (next 5 years)+6.70%
Revenue growth (last year)-4.77%
P/E ratioNM
Price/Sales1.36
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp+1.79+2.79%
AAAPAdvanced Accelerator...-0.11-0.36%
MYGNMyriad Genetics Inc+0.22+1.31%
VIVOMeridian Bioscience ...+0.20+1.12%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$2.5B
Annual profit (last year)-$16.0M
Net profit margin-0.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts